Results 151 to 160 of about 510,182 (210)

The Type I Interferon Axis in Systemic Autoimmune Diseases: From Molecular Pathways to Targeted Therapy. [PDF]

open access: yesBiomolecules
Ishihara R   +7 more
europepmc   +1 more source

BATF2 is a glutamine-responsive tumour suppressor required for type-I interferon-dependent anti-tumour immunity. [PDF]

open access: yesNat Commun
Gong W   +34 more
europepmc   +1 more source

Epigenetic lockdown of type I interferon sensing and signalling in human pluripotent cells

open access: yes
Holt JH   +5 more
europepmc   +1 more source

Self-aggregating Lactiplantibacillus plantarum enhances type-I interferon responses via the cytosolic sensors NOD2 and cGAS. [PDF]

open access: yesGut Microbes
Solis S   +6 more
europepmc   +1 more source

Type I Interferon Pathway Activation Disrupts Monocyte Maturation and Enhances Immune Evasion in Multiple Myeloma. [PDF]

open access: yesAdv Sci (Weinh)
Cui J   +18 more
europepmc   +1 more source

Natural killer cells aggravate neuroinflammation through microglial type I interferon pathway activation after traumatic brain injury. [PDF]

open access: yesJ Neuroinflammation
Nie M   +12 more
europepmc   +1 more source

Reduced Type-I Interferon by Plasmacytoid Dendritic Cells and Asthma in School-Aged Children. [PDF]

open access: yesAllergy
Coenen I   +14 more
europepmc   +1 more source

Correction: Genetic polymorphisms in cGAS-STING-mediated type I interferon innate immune signaling pathway are associated with DLBCL. [PDF]

open access: yesFront Immunol
Zhou Q   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy